Literature DB >> 8258158

Antibody Targeted Photolysis.

M L Yarmush1, W P Thorpe, L Strong, S L Rakestraw, M Toner, R G Tompkins.   

Abstract

The technique of Antibody Targeted Photolysis (ATPL) is reviewed from an historical perspective with a summary of the literature since the first experiments were performed in 1983. Attention is given to both the biological and photophysical properties of the various immunoconjugates that have been developed. References to critical discoveries and competing technologies in the photodynamic literature are given. Topics include: synthesis of immunoconjugates, in vitro vs. in vivo toxicity, in vivo biodistribution, immunoconjugate delivery, photosensitizer selection based on photophysical properties, light delivery for specific applications, oxygen requirements, and other physicochemical phenomena. A mathematical model of the dynamics for cell killing based upon the transport of phototoxins to the cell surface is developed. A generalized set of coupled differential equations is given, which conveniently summarizes the manifold requirements stressed earlier for successful cell killing. Solutions are then presented for an idealized set of conditions appropriate for an isolated tumor cell. Suggestions for further improvements and follow-up experiments are made that could help in the evolution of ATPL into a useful clinical therapy and/or probe for cell biological studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258158

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  6 in total

1.  A theoretical formalism for aggregation of peroxidized lipids and plasma membrane stability during photolysis.

Authors:  N A Busch; M L Yarmush; M Toner
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

Review 2.  Toward a molecular understanding of the photosensitizer-copper interaction for tumor destruction.

Authors:  Saleh Al-Omari
Journal:  Biophys Rev       Date:  2013-04-04

Review 3.  Current status of photodynamic therapy in oncology.

Authors:  R van Hillegersberg; W J Kort; J H Wilson
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

4.  Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer.

Authors:  L R Duska; M R Hamblin; M P Bamberg; T Hasan
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Biodistribution of charged 17.1A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer.

Authors:  M R Hamblin; M Del Governatore; I Rizvi; T Hasan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

Review 6.  Prospects in the Application of Photodynamic Therapy in Oral Cancer and Premalignant Lesions.

Authors:  Rajan Saini; Nathan V Lee; Kelly Y P Liu; Catherine F Poh
Journal:  Cancers (Basel)       Date:  2016-09-02       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.